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4. Groot farmaseutiese firmas speel ook al meer en meer n
belangrike rol in die navorsing na siektes en middels. In
die verlede was daar dikwels die neiging vir die medies-
geskoolde navorser en y koUega in die fannaseutiese nywer-
heid om mekaar e bydraes te misken. In hierdie opsigte
het dinge nou radikaal verander. Daar is nou egter baie
meer fasette verbonde aan mediese navorsing en diens as
ooit tevore. As ons die nodige brue kan bou, behoort die
mediese en farmaseutiese professies saam te staan in 'n
kragtige front teen onkunde en siekte.
Die wetenskaplike navor er in die algemeen, en, sover as
wat dit ons aangaan, die mediese wetenskaplike navorser
in die besonder, in watter hoedanigheid hy ook al werk,
beklee 'n sleutelposisie in ons ontwikkelende beskawing.
Om die beste belegging vir die toekoms te maak, moot ons
ons navorsers versigtig uitsook, hulle heelhartig aanmoedig
en ondersteun, en dit vir hulle moontlik maak om hul
bydraes op die hoogste vlak te lewer.
CONTROL OF POTENTIALLY HARMFUL DRUGS
It had been proposed by the Minister of Health to introduce
legislation amending Section 65bis of tbe Medical, Dental
and Pharmacy Act during the present session of Parliament.
However, agreement could not be reached between the
various interested parties. The Medical Association and the
Pharmaceutical Society of South Africa are opposed to
the proposed amendments, and in favour of amendments
put forward by the South African Medical and Dental
Council and the South African Phannacy Board.
It has therefore been decided not to proceed with the
proposed amendments until agreement can be reached. The
Secretary for Health has informed the Association that,
pending the introducticn of suitable amendments, it is the
intention of the Minister to relax administratively the appli-
cation of the less important provisions of Section 65bis.
Accordingly, no action will be taken in the meantime in
respect of minor technical infringements made in good
faith. The Secretary for Health points out, however, that
prosecutions will still be instituted in the case of deliberate
infringements.
We appeal to all our members to observe the spirit of the
law, and remind them that, while minor technical infringe-
ments will not be penalized, persons who attempt to flout
the requirements of the law or deliberately infringe the
provisions of Section 65bis will still lay themselves open to
prosecution.
In the Journal for 26 ovember 1960 we published an
editoriaP detailing the provisions of Section 65bis and
appealing to doctors to put their house in order regarding
prescriptions they write for potentially barmful drugs. At
that time pharmacists had made the point that many doctors
were contravening various provisions of this Sectiop of the
Act, and, while it may be that matters have improved in
the intervening months, it may be of value to set forth the
provisions of the Section once again as they stand at present.
Section 65bis lays down the requirements for prescriptions
for potentially harmful drugs extremely clearly. Xt states
that these prescriptions should include the following in-
formation: The date of issue of the presCription; the name
and address of the patient; the name and quantity of the
drug to be supplied, the number of times and the intervals
at which the prescription should be dispensed and, except
in the case of a preparation for external use, the amount
and frequency of each dose to be taken; and the usual
signature, address, and professional qualifications of the
doctor who issued the prescription, which prescription
should be in the doctor's own handwriting.
Provision is also made, in the case of an emergency, for a
pharmacist to supply potentially harmful drugs on the
telephonic instructions of a doctor personally known to
him. A prescription in the prescribed form, covering such
instructions, should then be fonvarded within twenty-four
hours by the doctor to the pharmacist.
Until agreement is reached and suitable amendments
passed by law, Section 65bis still- stands. As soon as such
amendments have been made we shall inform tbe profession;
until such time we appeal once again to our members to see
to it that they observe the requirements of the law regarding
these prescriptions.
I. Editodal (1960): S. Air. Med. J., 34, 1009.
THE MAST CELLS AND MASTOCYTOSIS*
WITH SPECIAL REFERENCE TO BONE CHANGES
FELIX SAGHER, M.D. and ZVl EVEN-PAZ, M.B., CH.B.
Department of Dermatology and Venereology, Hadassah University Hospital, Jerusalem, Israel
Paul Ehrlich was the first to describe the mast cells clearly.
What is more, be did this in his first scientific paper which
was published in 1877 when he was still a 23-year-old studenU
His paper contained a plate of drawings of granular cells
stained with aniline dyes, and he described their metachro-
* Guest lecture presented at the Congress of the Dermatological
Sub-Group (M.A.S.A.), Cape Town, 17 April 1960.
matic staining with dahlia violet. Two years later he gave
these cells a name.! Influenced by the fact that they were
most numerous where there was increased local nutrition as
a result of chronic inflammation or lymph stasis, he believed
them to be overnourished cells, and therefore called them
'mast cells'. In the same way an overfed goose is known in
many parts of Europe as a 'gemastete Gans',
How these mast cells fitted into the human economy.
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however, was completely unknown and it was not until 10
years later that Unna3 described the accumulation of these
cells in the lesions of a rare skin di ease called urticaria
pigmentosa or ettleship's disease'. This disease was first
described in 1869 by the young Briti h doctor, ettleship,'
who later became an ophthalmologist. He presented the case
of a 2-year-old girl with an unusual form of urticaria in which
the wheals were very persistent and left a light-brown hyper-
pigmentation. Rubbing the lesions cau ed urtication.
Both this disease and the mast cell itself remained medical
curiosities. Only in the last 10 or 20 years ha more light been
shed on these subjects. The 'riddle of the mast cell' haS by
no means been solved, but it is proving to be one of the most
fascinating of the cells found in animal connective tissue.
In fact, it seems to have been something of a dark horse;
it may yet prove to be a master cell of the connective tissue.
The chief characteristic .of the mast cell is the presence in
its cytoplasm of granules which stain metachromaticaIly.
By this is implied that the granules change the colour of the
dye used in staining them.
Recent biochemical and histochemical studies have
suggested an impressive number of possible functions for the
mast cell. Since these cells are present in any area of con-
nective tissue, and since connective tissue is so widely dis-
tributed, their physiologic activity is of great interest. This
is especially so now that· it is known that hormones such as
the steroids exert their effects largely as a result ofconnective-
tissue response. It seems that the mast cells produce or store
in their granules a number of powerful substances. These.
seem to be similar to or identical with heparin,5 hyaluronic
acid6 and histamine.7 It has been claimed with less convincing
evidence that serotoorn, or 5-hydroxy-tryptamine, is also
contained in mast cells. These agents may be released by
imple extrusion of granules, new ones forming within the
cell, or sometimes as a result of total disintegration of the cell.
FUNCTIONS OF MAST CELLS
The following is a list of possible functions of mast cells
related to a knowledge of the actions of these various
chemicals:
1. Heparin production
(a) Prevention of blood coagulation
(b) Local detoxification
(c) Formation of collagen
(d) Inhibition of hyaluronidase
(e) Metabolism of fats
2. Hyaluronic-acid production
(a) Integrity of the ground substance
3. Histamine production
(a) Activation of defence and repair mechanisms (?)
4. Serotonin production (?)
1. Heparin Production
(a) Prevention of blood coagulation. The mast cell has been
regarded as a single-celled endocrine gland pouring heparin
into the blood stream. Although there is umally no obvious
bleeding tendency in urticaria pigmentosa, and blood coagu-
lation studies are often quite normal, cases have been described
in which there were petechial eruptions and large purpuric
areas in and around the lesions.
case in a hild reported b \ aters and La n • is of especial
interest. The child de el ped uraneou lesi n of uniria pig-
mentosa in the first \ ee of life. From the ag of 3 ears there \
a tendency to bruise ea ily and a diffi ul!)' in arresting haemorrhage
after minor trauma. The child de eloped leukaemia, in \ hi h
ti sue ma t cell appeared in the blood. Bleeding time became pro-
longed and the prothrombin acti ity \ a redu ed. Death curred
follo\ ing the rupture of a large ubcap ular haematoma in the
liver. t autopsy the bl d in the peritone.al ca ity wa fund t
be enrirel fluid, and no clot had formed.
Some experiment on hibernating animal are rele ant in
this re peet. IO It i known that the blood-clotting lime of
these animal is hort during the active ummer period and
prolonged during \ inter hibernation. Bat in ummer \ ere
kept under temperature condition of 5°C. Their blood-
clotting time increa ed and 0 did the number of m t cell
in the duodenum. When \ inter bat were exposed to a tempera-
ture of 23°C. the rever e was observed. It seemed that the
alterations in clotting time were at lea t partly determined by
the availability of mast-cell heparin.
(b) Local detoxification. The theory ha been advanced that
heparin or related ub tances may neutralize noxiou amine
resulting from cell death, metabolic proce ses or other
factors. ll The complexes formed are then taken up by ordinary
fibroblasts. This theory is ba ed on some well-conducted ex-
periments.
(c) Formation ofcollagen. It has been shown that heparin can
precipitate collagen fibrils from procollagen,12 which may be
secreted by fibroblasts in the inflammatory response. How-
ever, a number of other sub tances be ides heparin may al 0
cause such precipitation of collagen fibril .
(d) Inhibition ofhyaluronidase. Heparin is capable of inhibit-
ing the action of hyaluronidase. Thi may indicate that mast
cells play a part in the defence of the connecti e ti ue again t
bacterial invasion or the spread of malignant tumour .
(e) Fat metabolism and atherosclerosis. Heparin eem to be
concerned in the normal transport and metabolism of fat by
stimulating 'clearing factor' production. Thi. factor break
up the large emul ified fat droplets in the blood tream, thus
facilitating the pa age of neutral fat through the capillary
walls.13 It has been further shown, as a re ult of animal
experiments and a study of human autop y material, that
subjects with marked atherosclero is have ignificanlly
re·duced mast-cell counts in the cardiac muscle and other
tissues.14 The autopsy reports 0 far published on patient
dying from malignant mastocyto i have made no peeial
comment on the presence or absence of athero c1ero i , even
in aged per ons. It might be of value if in future special
attention wa paid to this aspect,15
2. Hyaluronic-acid Production
The opinion that hyaluronic acid i secreted by mast cell i
based on a good deal of experimental evidence. Any increa e
in water content of the ground sub lance of connective ti ue
seem to cause an increase in the number of ma t cells, which
then undergo di ruption. The hyaluronic acid liberated con-
vert the free water into a hydrated gel and a perivascular
oedema is changed into a mucinous mat<.rial. Thus the phy ico-
chemical integrity of the ground ub tance i preserved.
3. Histamine Production
Although hi tamine ha well-known and powerful pharma-
cological actions it place in normal phy iology i not clear.
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Its release from mast cells in response to trauma or other
damage to the tissues might flood the areas with protein-rich
oedema fluid as a result of increased vascular permeability.
This might then mobilize the fixed tissue cells before the
proce s of repair. .
The urtication which may occur on rubbing the lesions of
urticaria pigmentosa is most easily explained on the basis of
the local liberation of a hi tamine-like substance. There have
also been reports of more generalized disturbances in this
disease attributed to release of hi tamine. These include
attacks of generalized flushing, either spontaneously or as a
result of irritation of the le>ions. More severe disturbances
resembling 'histamine-shock', sometimes with loss of con-
sciousnes , have al 0 been described. In some cases such
attacks ceased after excision of a large, active, mast-cell
tumour. IS More attention has been paid to this peculiar, but
rare, associated phenomenon in recent years, and some cases
have been described in South AfricaY In some of the cases
the histamine content of the lesions, the blood, and the urine
was much increased.
4. Serotonin Production
It is less certain whether serotonin (5-hydroxy-tryptamine,
5-H]) is contained in human mast cells, although it seems to
be present in the mast cells of rats. This substance is present
in the enterochromaffin cells of the intestinal tract and in
carcinoid tumours of these cells. It is also found in blood
platelets and in some cells of the nervous system. The symp-
toms of the release of serotonin include, among others, such
vasomotor disturbances as generalized flushing. It also causes
intestinal hypermotility, and in this respect it is of interest
to note that abdominal pain and diarrhoea have often been
found in association with urticaria pigmentosa.
However, there is no clear evidence of raised serotonin levels
in either the lesions or the blood of patients with this disease,
nor has there been an increase of its metabolic end-product
in the urine of these patients. Further investigation is therefore
necessary to decide whether serotonin, either alone or com-
bined with histamine, plays any part in the many-faceted
symptomatology of mastocytosis.
Summary 0/ .Functions
So far as present knowledge goes, mast cells may be consider-
ed as unicellular endocrine glands. They apparently secrete a
number of very powerful agents-heparin, hyaluronic acid,
histamine, and possibly serotonin-mainly as part of the
mesenchymal reaction in time of stress. The cells respond
both to local tissue changes and to alterations in the general
balance of the body hormones.
URTICARIA PIGM:E1'o'TOSA OR MASTOCYTOSIS
This disease, like the mast cell itself, has emerged from relative
obscurity only in the last decade. In spite of earlier reports
of occasional enlargement of lymph glands and rather vaguely
defined blood disturbances, we were all taught that this
disease was a mere dermatological curiosity with no real
significance as regards the general health of the patient.
Most cases still do seem to be confined to the skin and to be
entirely benign, but each year further cases are reported in
which systemic involvement has been detected. This sys-
temic involvement may also be benign, but it occasionally
takes a malignant course and may prove fatal. At least 12
fatal cases have been described.
The ystemic involvement takes the form of mast-cell
irifi!trations in the lymph nodes, liver, spleen, bones, hae-
mopoietic system, and sometimes other organs.18 Lupus
erythematosus was once also considered a purely derma-
tological condition; then it was found not only to have
possible systemic 'associations, but also to exist in a purely
systemic form without skin lesions. By analogy it was pro-
phesied that one day a purely systemic form of urticaria
pigmentosa would be detected. Such cases without any
cutaneous involvement have now been described, e.g. a purely
'splenic mastoCytOSIS',a and a condition of 'mast-cell
leukaemia'.2o.21 Therefore, the use of the general term
<mastocytosis' instead of urticaria pigmentosa seems fully
justified.
Recent literature contains a number of excellent short sur-
veys on urticaria pigmentosa, and among the best of these is
certainly that of Marshall et alY These authors proposed an
interesting system of classification of the mastocytoses. We,
too, had been thinking on somewhat similar lines and the





(b) Disseminated (benign urticaria pigmentosa)
(i) Juvenile type
(ii) Adult type
(c) Diffuse (mastocytose diffuse cutanee)
2. Cutaneo-systemic mastocytosis
Any of the forms listed under cutaneous mastocytosis,
with associated mast-cell invasion of. lymph nodes, liver,




Involvement of the above-mentioned structures, together
with the viscera, but without lesions of the skin.
It is now clear that the complete and accurate diagnosis of
a case ofurticaria pigmentosa or mastocytosis must be based,
in addition to the dermatological examination, upon a
thorough general clinical exarnination; a full haematologic
study, including that of the coagulation mechanism; an
examination of the bone marrow or histologic study of a
bone biopsy specimen; and a complete radiological study of
the entire skeleton.
Although there were earlier hints and suggestions that
urticaria pigmentosa might in some way be a systemic disease,
these have only r~ently been substantiated. In 1949 Ellis22
reported on an autopsy performed on a one-year-old child
who died in the active stage of the disease. During life there
had been no suspicion of systemic involvement, but tbe
postmortem examination revealed numerous mast-cell infil-
trations in the bone marrow, thymus gland, liver, spleen,
pancreas, and lymph nodes.
Tissue mast cells in the blood were first described by
Hissard and co-workers23 in 1950, in a case with the diffuse
type of skin involvement. Although the usual number of
mast cells in the circulating blood was only 1-2%, they rose
to 45 % following splenic puncture, which presumably induced
contraction of the spleen. The patient eventually died.
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Fig. J. Cutaneous lesion from a
patient with mastocytosis. Mast cells
are dispersed throughout the middle
and upper dermis. One month later
the patient died from monocytic
leukaemia (toluidine blue X 470).
Bone Changes
The existence of widespread bone changes in a patient with
urticaria pigmentosa was first demon trated by -ray ex-
amination in 1950 in Israel.U
The patient was a 53-year-old man whose \ idespread kin
lesions had appeared 4 years earlier. He wa admitted to hospital
for thorough general examination. An X-ray picture of the chest
showed that the ribs were involved by a cystic osteoporotic proce s,
with punched-out area and thickening of the trabeculae. The
changes resembled those seen in multiple myeloma or metastatic
carcinoma.
Since the pattern of the X-ray shadows was reminiscent
of that produced on the skin by the pigmented le ions, it \ as thought
that they might be due to the same process. Sclerotic bone changes
were found in the sJrull, the pelvis and the lumbar vertebrae. The
bones of the extremities seemed unaffected. 0 mast cells were
detected in the bone marrow and the patient refused toallowdiag-
nostic costotomy. Follow-up X-ray studies performed over a period
of 7 years revealed progression of the sclerotic process in the bones,
even though the patient remained in relatively good general health.
The late Dr. Charles C. Rein of Tew York visited our
clinic and saw this patient. On his return to the USA he re-
examined all his patients with urticaria pigmentosa, and
together with Dr. Clyman25 reported a case of this disease
with localized bone changes. They suggested that a central
registry should be set up in Jerusalem to which reports on
skeletal studies in urticaria pigmentosa might be forwarded.
As a result of cases reported to this registry,:5 and of others
described in the literature, it seems that a total of well over
30 cases of this disease with osseous changes have been detected
since 1952. It is not possible to be certain how many cases
there have been in which X-ray studies were performed, but
showed no changes, since many of these will have gone
unreported. Two out of 20 cases examined in our clinic had
bone changes. -
The second of these 2 patients is of especial interest. 27,28 She \ as
a 55-year-old woman with urticaria pigmentosa of the maculo-
papular type, of 5 years' dura-
tion. Her general health, at first,
was good. Skeletal X-ray examin-
ation, which was a routine pro-
cedure since the finding of bone
changes in the first patient,
showed that she, too, had
generalized bone changes. This
patient was under observation
for 2t years. Then, her general
health suddenly deteriorated and
she developed a high fever and
died with a clinical picture of
monocytic leukaemia.
A comparison of the first
X-ray pictures with those taken
shortly before her death, showed
that there had meanwhile been
a marked progression of the
sclerotic changes, both in the
areas originally affected and in
bones which had previously ap-
peared normal. Thus, in the
earlier pictures the margins of
the inner and outer tables of
the skull were distinct, and islets
of increased density could be
seen scattered throughout the
bones. In the later X-ray pic-
tures islets could not be seen,
for the outer and inner tables
now formed one continuous un-
differentiated sclerotic mass. In
the later pictures the previously
Fig. 2. Same patient as Fig. I. Cutaneous lesion removed at autopsy. A. Low
power. There is a dense cellular infiltration of the entire dermis (toluidine blue
X 125). B. High dry power. The infiltrate consists of monocytes, with inter-
mingled mast cells.
Fig. 3. Same patient as Fig. I. Lumbar venebra. A and B. Aggregations of
tissue mast cells in the bone marrow, Mast ceUs are also seen lining large.
empty, vascular spaces (toluidine blue X 400).
normal-looking distal portions of the radius and ulna, and the
carpal and metacarpal bones, were een to have become involved
by the same sclerotic proces .
Shortly before death the patient de eloped a leukocyto i , rising
to 248,000 white blood cells per c. mm. Seventy-eight %of the cells
were monocytes, some of which were classed as 'atypical'. utopsy
studies confirmed the clinical diagno i , and proved that the changes
in the bones seen at X-ray were indeed due to mast-cell infiltra-
tions. Many of the marrow spaces were either completely fibrosed
or were filled with accumulations of mast cells. These cells were
also present \vithin large, empty: ascular paces (Figs. 1-5).
The bone changes 0 far described in mastocyto i may be
clas ified in two groups: Generalized or diffuse involvement,
and localized involvement.29
In generalized or diffuse involvement, exemplified by the
cases I have described, the le ions seen in the X-ray pictur
are difl\:sely cattered throughout the affected bone. The
bones mo t frequently affected are tho e of the central column
of the body-i.e. the lrull, vertebrae, rib and pelvi. early all
the patients in which this type of involvement ha been
described were over 30 year of age.
In localized involvement, the chang are een a localized
area, sometime with a harply 'punched-out' appearance,
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Fig. 4. Same patient as Fig. I. Lumbar vertebra. Accumulation of mast cells in
marrow space, whicb also bows early fibro is (toluidine blue X (05). Inset:
Typical mast cells in tbe marrow space (X 370).
confined to one part of the affected bone. The skull and the
bones of the extremities have shown such lesions, but the
ribs and vertebrae are usually not involved. This type of bone
lesion has been described in children as well as in adults.
Treatment
On the subject of the treatment of mastocytosis I will say
little. Much has been tried, but, in general, with far from satis-
factory results. Antagonists of heparin, histamine, hyaluronic
acid, and serotonin have been tried, in addition to steroids,
radiation therapy, and many less specifically directed pro-
cedures. The chief importance of treatment once seemed to
be only cosmetic, but now that possible sy. temic and fatal
developments must be considered, the search for effective
treatment takes on a new urgency.
It seems likely that the solution will be Imked to a greater
understanding of the 'riddle of the mast cell'.
SUMMARY
1. The possible functions of the mast cells are discussed.
2. Their association with urticaria pigmentosa is described.
3. The disease urticaria pigmentosa, or mastocytosis, is
described in detail and a tentative classification of the masto-
cytoses is given. The widespread nature of mastocytosis is
stressed, with special reference to the bone changes and the
possibility of malignancy.
4. The unsatisfactory nature of the available treatment of
mastocytosis is mentioned, and the urgency of finding effective
treatment is stressed.
Fig. 5. Same paHent a Fig. I. Lumbar vertebra. A. Tbe marrow pace sbow fibrosis and contain an accumulation of mast cells (haematoxylin and eosin X 33).
B. Higher magnification. Tbe irregularly thickened trabeculae consist of a depa ;,ion of immature markedly basophilic, fibrillary bone upon the mature
bone ( X 160).
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THE PRESENT-DAY STATUS OF THE CONSTRICTIO RI GS OF LABOUR
BASIL BLOCH, M.B., CH.B., M.MED. (0. & G.) (CAPE Tow'), M.R.C.O.G.
Obstetrician and Gynaecologist, Port Elizabeth
In spite of the noteworthy advances in most obstetrical fields
during the past two decades, one of the subjects which still
remains highly speculative is the physiology of uterine-muscle
contractility. The aetiology of constriction-ring dystocia is
closely linked with the physiology of uterine action, and it is
for this reason that it remains obscure, with the treatment
unsatisfactory. On the surface it would appear that the
management of this condition is straightforward, but any
complacency that exists will soon be dispelled by a glance at
the appallingly high foetal and maternal mortality and
morbidity rates. A review of the subject was undertaken to try
to assess the correct lines of treatment when faced with this
not uncommon condition.
Definition
The term constnctlOn ring refers to an abnormality of
uterine contractility during labour either due to, or respon-
si ble for, the production of a ridge of uterine muscle, which is
,circular or nearly so, and which projects into the uterine
cavity or disturbs its normal shape.
Incidence
The estimations vary, but the incidence of this condition
is probably nearer 0'1 %1 than 1%2.3 of all labours. Primi-
gravidae, multigravidae and grande-multiparae may all be
affected.
TYPES
Rudolph4 has divided these rings into 2 varieties:
1. Reversible. This is simply a spasm affecting a localized
circular area of the muscle of the uterus (Fig. 1). It can develop
quite quickly following intra-uterine manipulation, or the
administration of oxytocic drugs in the presence of hyper-
tonus. This is the type of ring which should in theory respond
to conservative measures.
2. Irreversible. Here there is a thick localized ridge of
uterine muscle which projects into the cavity of the uterus
and grips the foetus (Fig. 2).The upper segment is thinned out
from the uterine fundus towards the ring, and the lower
egment usually presents the same appearance. It would
eem that this type of ring usually occurs in as~ociation with
abnormal uterine action and is demonstrable at Caesarean
section. It persists even after death as shown by Phillips~ and
Louw.6 Philiips regard this condition as the end-re ult of a
colicky uterus in an extreme degree, where the pa m a umes
an annular di tribution.
In a review of 371 ca es collected from the literature,
Rudolph4 further subdivided these constriction ring into:
A. Those palpable internally (91 %).
1. Around the baby's neck, behind the ymphy i pubi
(75%).
2. Around the baby's body, above the ymphysis pubi
(16%).
3. In front of the presenting part, behind the ymphy i
pubis (9%).
B. Those palpable externally (9 %).
Sites
(a) The junction of the upper and the lower segments. Thi
is the commonest site, and here it is important to di tinguish
between a constriction ring and a Bandl' ring or retraction
ring (Fig. 3). A retraction ring is the normal demarcation
between the upper and lower segments that can be felt
from time to time a a light ring-like elevation in the cavity
of the uterus.
(b) In the upper segment. The e rings have been described
as occurring most commonly around the infant's neck, waist,
or limbs, but it is conceivable that they ari e anywhere in the
upper segment due to contraction of the circular mu de
fibres over a point of slight resistance.
(c) In the lower segment. This is a rare site for the occur-
rence of constriction rings, and some doubt has been ca t
. on whether they arise here at all. •
It is al 0 worth remembering that the ring may be better
developed either on the left or right,6,? or even anteriorly or
posteriorly. That more than one site may be affected imul-
taneou Iy has also been shown.
AETIOLOGY
As ha been pointed out, the dj turbance is basically one of
uterine function in labour, which re ult in the constriction of
an area of circular mu de fibre. Thi may occur at variou
level in the uteru .
Rudolph and Ivy4·8 demonstrated that phy iological
constriction rings form in the uteri of pluriparous animal,
where the foetu i contained in segment of the two uterine
